Ocugen Stock (NASDAQ: OCGN) stock price, news, charts, stock research, profile.
Open | $1.700 |
Close | $1.670 |
Volume / Avg. | 5.386M / 10.093M |
Day Range | 1.615 - 1.715 |
52 Wk Range | 0.345 - 2.105 |
Market Cap | $424.591M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 17.85% |
Days to Cover | 4.36 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ocugen (NASDAQ: OCGN) through any online brokerage.
Other companies in Ocugen’s space includes: Voyager Therapeutics (NASDAQ:VYGR), PepGen (NASDAQ:PEPG), Replimune Group (NASDAQ:REPL), Fate Therapeutics (NASDAQ:FATE) and Anika Therapeutics (NASDAQ:ANIK).
The latest price target for Ocugen (NASDAQ: OCGN) was reported by Chardan Capital on Monday, April 22, 2024. The analyst firm set a price target for 5.00 expecting OCGN to rise to within 12 months (a possible 203.03% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Ocugen (NASDAQ: OCGN) is $1.65 last updated May 9, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Ocugen.
Ocugen’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Ocugen.
Ocugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.